New Lilly, BI diabetes med hits shelves; AstraZeneca launches online tool for docs;

> Eli Lilly ($LLY) and Boehringer Ingelheim's new Type 2 diabetes treatment Jardiance is now available in U.S. pharmacies. Release

> AstraZeneca ($AZN) has launched a new online tool in the U.S. to help medical professionals keep better up to date with their areas of study. More

> Valeant Canada has acquired Valeo Pharma's dermatology product portfolio and several specialty products. Release | Report

> Copenhagen has become the second city involved in Novo Nordisk's ($NVO) global "Cities Changing Diabetes" campaign. Story

> Mylan ($MYL) chose three kids with potentially life-threatening allergies to join NFL star Adrian Peterson to film an educational video about anaphylaxis. Release

And Finally... Merck ($MRK) has started the second year of a 5-year project to fight diabetes by supporting E-Learning in Africa. More

Suggested Articles

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Call it a fall sports bounce. TV ad spending bumped up in August with the partial return of professional sports, and that included pharma buyers.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.